Relay Therapeutics Completes $63M Series B Financing

Retrieved on: 2017-12-13 20:11:15

Tags for this article:

Click the tags to see associated articles and topics

Relay Therapeutics Completes $63M Series B Financing. View article details on hiswai:

Excerpt

<div>Relay Therapeutics, a Cambridge, Mass.-based biotech company dedicated to developing medicines by leveraging insights from protein motion, completed a $63m Series B financing. The round was led by BVF Partners, with participation from new investors GV (formerly <b>Google Ventures</b>), Casdin ...</div>

Article found on:

View Original Article